Miki Yamaguchi

1.9k total citations
89 papers, 1.4k citations indexed

About

Miki Yamaguchi is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Miki Yamaguchi has authored 89 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 24 papers in Oncology and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Miki Yamaguchi's work include Breast Lesions and Carcinomas (16 papers), Cancer and Skin Lesions (12 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Miki Yamaguchi is often cited by papers focused on Breast Lesions and Carcinomas (16 papers), Cancer and Skin Lesions (12 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Miki Yamaguchi collaborates with scholars based in Japan, United States and China. Miki Yamaguchi's co-authors include Kenji Ikebuchi, Norihiro Sato, Hisami Ikeda, Fumiya Hirayama, Yuji Sakuma, Sachie Hirai, Mitsuhiro Fujihara, Toshiyuki Sumi, Hiroshi Azuma and Atsushi Watanabe and has published in prestigious journals such as Blood, Cancer Research and Journal of Virology.

In The Last Decade

Miki Yamaguchi

83 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miki Yamaguchi Japan 20 438 294 287 260 253 89 1.4k
Aibin Liang China 19 689 1.6× 498 1.7× 114 0.4× 103 0.4× 247 1.0× 117 1.5k
Stephen Fitter Australia 24 709 1.6× 339 1.2× 644 2.2× 113 0.4× 317 1.3× 39 1.8k
Endi Wang United States 24 557 1.3× 546 1.9× 351 1.2× 164 0.6× 440 1.7× 127 2.0k
Elena Tenedini Italy 24 933 2.1× 290 1.0× 331 1.2× 89 0.3× 500 2.0× 53 1.7k
Kathleen Tomkinson United States 12 670 1.5× 166 0.6× 161 0.6× 115 0.4× 176 0.7× 17 1.4k
Eric M. Bindels Netherlands 23 984 2.2× 238 0.8× 517 1.8× 146 0.6× 275 1.1× 75 1.7k
Ko Sasaki Japan 21 602 1.4× 290 1.0× 267 0.9× 102 0.4× 110 0.4× 78 1.3k
Mary Callanan France 22 957 2.2× 431 1.5× 190 0.7× 76 0.3× 307 1.2× 67 1.9k
Meera Ramanujam United States 26 376 0.9× 212 0.7× 143 0.5× 234 0.9× 146 0.6× 42 2.2k
Lenka Sedlaříková Czechia 13 616 1.4× 277 0.9× 290 1.0× 83 0.3× 115 0.5× 33 1.0k

Countries citing papers authored by Miki Yamaguchi

Since Specialization
Citations

This map shows the geographic impact of Miki Yamaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miki Yamaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miki Yamaguchi more than expected).

Fields of papers citing papers by Miki Yamaguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miki Yamaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miki Yamaguchi. The network helps show where Miki Yamaguchi may publish in the future.

Co-authorship network of co-authors of Miki Yamaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Miki Yamaguchi. A scholar is included among the top collaborators of Miki Yamaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miki Yamaguchi. Miki Yamaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yamaguchi, Miki, Sachie Hirai, Masashi Idogawa, et al.. (2024). A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma Cells. International Journal of Molecular Sciences. 25(16). 8748–8748. 3 indexed citations
3.
Sakuma, Yuji, Sachie Hirai, Toshiyuki Sumi, et al.. (2021). MCL1 inhibition enhances the efficacy of docetaxel against airway-derived squamous cell carcinoma cells. Experimental Cell Research. 406(2). 112763–112763. 4 indexed citations
5.
Tanaka, Yusuke, Miki Yamaguchi, Sachie Hirai, et al.. (2018). Characterization of distal airway stem-like cells expressing N-terminally truncated p63 and thyroid transcription factor-1 in the human lung. Experimental Cell Research. 372(2). 141–149. 16 indexed citations
6.
Ikeda, Masahiro, Miki Yamaguchi, Kazunori Kato, et al.. (2015). Pr1E11, a novel anti-TROP-2 antibody isolated by adenovirus-based antibody screening, recognizes a unique epitope. Biochemical and Biophysical Research Communications. 458(4). 877–882. 17 indexed citations
7.
Yamaguchi, Miki, Kiminori Nakamura, Sachie Hirai, et al.. (2014). Development of a sensitive screening method for selecting monoclonal antibodies to be internalized by cells. Biochemical and Biophysical Research Communications. 454(4). 600–603. 17 indexed citations
8.
Yamaguchi, Miki, et al.. (2012). The Usefulness of Vacuum-assisted Biopsy for Diagnosis of Intracystic Tumor of the Breast. Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 21(2). 175–178.
9.
Yamaguchi, Rin, Maki Tanaka, Kazuhiro Kondo, et al.. (2010). Characteristic Morphology of Invasive Micropapillary Carcinoma of the Breast: An Immunohistochemical Analysis. Japanese Journal of Clinical Oncology. 40(8). 781–787. 25 indexed citations
10.
Yamaguchi, Rin, Maki Tanaka, Toshiro Yokoyama, et al.. (2009). Clinicocytopathology of breast cancers with a ring‐like appearance on ultrasonography and/or magnetic resonance imaging. Pathology International. 60(1). 22–26. 4 indexed citations
11.
Azuma, Hiroshi, et al.. (2004). Cytotoxic Difference of T Cells Expanded with Anti-CD3 Monoclonal Antibody in the Presence and Absence of Anti-CD28 Monoclonal Antibody. Stem Cells and Development. 13(3). 315–322. 8 indexed citations
12.
Yamaguchi, Miki, Fumiya Hirayama, Shinobu Wakamoto, et al.. (2002). Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion. Transfusion. 42(7). 921–927. 52 indexed citations
13.
Azuma, Hiroshi, Miki Yamaguchi, Mitsuhiro Fujihara, et al.. (2002). Functional evaluation of ex vivo expanded cord blood lymphocytes. Experimental Hematology. 30(4). 346–351. 16 indexed citations
14.
Yamaguchi, Miki, et al.. (2002). [A case report of intralobar pulmonary sequestration with an anomalous artery originating from the celiac artery].. PubMed. 40(3). 261–4.
15.
Hirose, Takanori, et al.. (1999). Invasive pituitary adenoma protruding into nasal cavity. A case report.. The Journal of the Japanese Society of Clinical Cytology. 38(1). 93–97. 1 indexed citations
16.
Yamaguchi, Miki, Kenji Ikebuchi, Fumiya Hirayama, et al.. (1998). Different Adhesive Characteristics and VLA-4 Expression of CD34+ Progenitors in G0/G1 Versus S+G2/M Phases of the Cell Cycle. Blood. 92(3). 842–848. 63 indexed citations
17.
Sawada, K, Masahiro Ieko, Atsushi Notoya, et al.. (1996). Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells. Blood. 88(1). 319–327. 17 indexed citations
18.
Takahashi, Tsuneo, et al.. (1994). Analysis of hematopoietic stem cells and progenitor cells in human umbilical cord blood.. Journal of the Japan Society of Blood Transfusion. 40(5). 737–743.
19.
Nishiyama, Masahiko, et al.. (1985). [Comparison of human tumor clonogenic and nude mouse-isotope assays in anticancer-agent sensitivity tests].. PubMed. 12(9). 1808–12. 1 indexed citations
20.
Hayashi, Yuki, et al.. (1969). [Case of eosinophilic granuloma of the bone].. PubMed. 20(9). 997–1000. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026